Patents Assigned to Nippon Menard Cosmetic Co., Ltd.
  • Patent number: 10259772
    Abstract: An object of the present invention is to find a novel substance that is capable of efficiently promoting the proliferation of stem cells while maintaining the undifferentiated state thereof and to provide the substance as an agent for maintaining the undifferentiated state of stem cells or an agent for promoting the proliferation of stem cells. Another object of the present invention is to provide an agent for treating a wound that has a wound healing effect on the skin and is readily available in the field of skin regenerative medicine or cosmetic treatment, and safe and inexpensive.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: April 16, 2019
    Assignee: Nippon Menard Cosmetic Co., Ltd.
    Inventors: Seiji Hasegawa, Yu Inoue, Yuichi Hasebe, Tsutomu Sakaida
  • Publication number: 20170320809
    Abstract: An object of the present invention is to find a novel substance that is capable of efficiently promoting the proliferation of stem cells while maintaining the undifferentiated state thereof and to provide the substance as an agent for maintaining the undifferentiated state of stem cells or an agent for promoting the proliferation of stem cells. Another object of the present invention is to provide an agent for treating a wound that has a wound healing effect on the skin and is readily available in the field of skin regenerative medicine or cosmetic treatment, and safe and inexpensive.
    Type: Application
    Filed: November 5, 2015
    Publication date: November 9, 2017
    Applicant: NIPPON MENARD COSMETIC CO., LTD.
    Inventors: Seiji HASEGAWA, Yu INOUE, Yuichi HASEBE, Tsutomu SAKAIDA
  • Patent number: 7618638
    Abstract: The object of the present invention is to provide a preventive and relieving medicine for activated matrix metalloproteinase-causing disorders and diseases, which contains a solvent extract of Ganoderma mushroom. The preventive and relieving medicine for activated matrix metalloproteinase (MMP)-causing disorders and diseases according to the present invention contains the solvent extract of Ganoderma mushroom. The solvent extract of Ganoderma mushroom has MMP inhibiting behaviors and is effective for prevention, suppression, and symptomatic relief of various activated MMP-causing disorders and diseases, such as metastasis of cancers, ulceration, rheumatoid arthritis, osteoporosis, periodontitis, and aging of skin.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: November 17, 2009
    Assignee: Nippon Menard Cosmetic Co., Ltd.
    Inventors: Koji Hattori, Hiroshi Mizutani, Kazuhisa Osumi